Eli Lilly sees U.S. prasugrel filing next week
28075
Eli Lilly and Co  plans to submit a U.S. application next week for its experimental blood-clot preventer prasugrel, the most important drug in its pipeline, a company spokesman said on Wednesday.
189940
LONDON (CBS.MW) -- US pharmaceutical Eli Lilly (LLY) suppressed evidence that its antidepressant drug Prozac could cause behavioural disturbances, the Financial Times reported Friday, citing allegations published in the British Medical Journal.
196823
A potent new anti-clotting drug from Eli  Lilly and Co proved as safe and effective as Sanofi-Aventis's  top-seller Plavix in a mid-stage clinical trial, researchers  said on Sunday.  Now Lilly and its partner Sankyo Co. Ltd. aim to demonstrate  clear superiority for their compound, known as prasugrel or  CS-747, in a much larger Phase III study involving up to 13,000  patients that is about to get under way.
524084
The warning that Eli Lilly &amp; Co. issued last week about its attention-deficit disorder drug Strattera is much narrower than was reported in Saturday&#39;s editions of The Times-Dispatch.
245874
Eli Lilly and Co.  said on Thursday it is on track to meet its 2006 growth forecast of 8 percent to 12 percent, but projected slower profit growth in 2007 though its revenues will grow at a faster pace next year.
729020
Eli Lilly and Co. LLY.N on Thursday  said that it expects 2005 earnings to rise as higher sales of  its newer drugs offset a decline in its top-selling  schizophrenia drug Zyprexa.
511580
The newest drug in its cabinet is expected to hit the U.S. market in the fourth quarter.
468404
Eli Lilly and Co. LLY.N on Thursday  said it expects 2005 earnings to rise as higher sales of its  newer drugs offset a decline in its top-selling schizophrenia  drug Zyprexa.
752198
Drug companies are racing to capture the ballooning market in diabetes care. Pfizer Inc. plans to debut Exubra, its new inhaled insulin treatment, in July, and Merck &amp; Co., Novartis AG and Eli Lilly and Co. are awaiting FDA approval for new diabetes products that could generate hundreds of millions of dollars in sales.
226044
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc  and Schering-Plough's  cholesterol  medicine Vytorin following the drug's failure to work better  than a generic drug in a study of plaque build-up in neck  arteries.
705384
Drugmaker Eli Lilly and Co. (LLY.N: Quote, Profile, Research) on Wednesday said it will make clinical trial information available online amid calls by lawmakers and physicians for more disclosure of negative trial results.
226791
A court ruling upholding the  patent on blockbuster blood-thinning drug Plavix has reignited  talk France&#39;s Sanofi-Aventis  will bid for its smaller  U.S. partner Bristol-Myers Squibb Co. .
38622
Eli Lilly and Co. on Thursday  reaffirmed it expects its 2006 earnings to rise 8 percent to 12  percent, but projected disappointing profit growth for 2007  even though its revenues will grow at a faster pace next year.
505571
The US Food and Drug Administration expects to inspect Boston Scientific Corp.&#39;s Galway, Ireland factory in the &quot;near future&quot; as part of its probe into the company&#39;s coronary stent recall, the Wall Street Journal said on Friday.
763482
Investors are likely to question why Lilly is still fiddling with the dosage of prasugrel.
264090
NEW YORK - As Wall Street sifts through more than 300 third-quarter earnings reports this week, technology and pharmaceutical stocks will be getting some of the closest scrutiny.    The focus on drug companies results from a recent spate of bad news about Merck & Co...
267076
Eli Lilly and Co. on Thursday reaffirmed it expects its 2006 earnings to rise 8 percent to 12 percent, but projected disappointing profit growth for 2007 even though its revenues will grow at a faster pace next year.